ENVALITH
株式会社ADR120S logo

Cytori Cell Research Institute,Inc.

3750Standard MarketInformation & Communication

株式会社ADR120S logo
Cytori Cell Research Institute,Inc.3750
Reference Indicators

Market Cap

72¥100M

P/E (Forecast)

359.2x

P/B

324.3x

Dividend Yield (Forecast)

0.00%

ROE

-180.0%

EV/EBITDA

Financial Summary
Unit: ¥M
Item
2022Mar 2022
2023Mar 2023
2024Mar 2024
2025Mar 2025
2026Mar 2026
Net Sales
1,3352,1441,56012250
Cost of Sales
47687526712840
Gross Profit
8591,2681,292-510
SG&A Expenses
1,3212,0632,065800916
Operating Income
-462-794-772-806-906
Non-operating Income
1428622245
Non-operating Expenses
981541568221
Ordinary Income
-418-862-906-864-922
Extraordinary Income
33607362614
Extraordinary Losses
33153541,29320
Pre-tax Income
-65-1,166-1,011-2,152-397
Income Taxes
11-106-1,150-12-0
Net Income
-77-1,059138-2,140-396
EBITDA
-141-462-518-757-905
Gross Margin
64.3%59.2%82.8%-4.9%20.7%
Operating Margin
-34.6%-37.0%-49.5%-660.3%-1777.2%
ROA
-0.5%-7.5%2.4%-60.5%-107.8%
ROE
-2.3%-35.6%5.5%-142.8%-180.0%